2023 international evidence-based guideline pcos glp-1 receptor agonist Polycystic ovary syndrome: An update on diagnosis and management GLP-1s and PMOS: PCOS, Insulin
Description
Therefore, therapeutic principles acting via different receptors and postreceptor pathways seem attractive in view of potentially additive or synergistic effects
Screening for Obesity in Children and Adolescents
2006;290:R634R641
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs)
GLP-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data
